Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Metabolism. 2016 Sep 22;65(12):1720–1730. doi: 10.1016/j.metabol.2016.09.003

Table 1.

Tissue weight and body composition at week 7 before APN treatment, and at week 14 after APN treatment.

Rag−/−
LFD
HFD
p-overall
(n=7) PL (n=8)
APN (n=6)
Variable week Mean ± SE Mean ± SE Mean ± SE
Fat Mass (g)** 7 0.89 ± 0.11 b 5.25 ± 0.72 a 5.23 ± 0.37 a 0.006
14 1.55 ± 0.24 6.01 ± 0.95 3.82 ± 0.15 0.24
change 0.72 ± 0.21 a 1.14 ± 0.64 a −1.41 ± 0.53 b 0.005
Fat Mass (%)** 7 3.48 ± 0.41 b 18.05 ± 2.01 a 18.00 ± 1.21 a 0.001
14 5.78 ± 0.81 17.93 ± 2.20 12.34 ± 0.34 0.09
change 2.39 ± 0.71 a 0.97 ± 1.50 a −5.55 ± 1.40 b 0.0001
Lean Mass (g)** 7 18.39 ± 0.46 a 17.86 ± 0.32 b 18.55 ± 0.23 a 0.001
14 19.22 ± 0.51 19.86 ± 0.37 20.28 ± 0.44 0.15
change 0.83 ± 0.09 b 2.00 ± 0.19 a 1.73 ± 0.30 a 0.03
Lean Mass (%)** 7 73.55 ± 0.48 a 62.28 ± 1.05 b 64.51 ± 1.25 b 0.0003
14 71.74 ± 0.49 a 60.89 ± 1.69 c 65.62 ± 0.73 b 0.03
change −1.81 ± 0.61 b −1.40 ± 1.16 b 1.10 ± 1.65 a 0.0004
Body Weight (g) 14 27.4 ± 0.7 b 31.8 ± 0.9 a 29.6 ± 0.8 ab 0.005
Heart (g) 14 0.12 ± 0.01 0.13 ± 0.01 0.13 ± 0.00 0.99
(%) 14 0.44 ± 0.02 0.41 ± 0.01 0.43 ± 0.02 0.98
Spleen (g) 14 0.02 ± 0.00 0.03 ± 0.00 0.05 ± 0.01 0.08
(%) 14 0.09 ± 0.01 0.09 ± 0.01 0.17 ± 0.05 0.07
Pancreas (g) 14 0.39 ± 0.10 0.27 ± 0.04 0.24 ± 0.01 0.48
(%) 14 1.03 ± 0.07 0.86 ± 0.13 0.79 ± 0.03 0.42
Liver (g) 14 1.04 ± 0.04 1.35 ± 0.06 1.14 ± 0.02 0.06
(%) 14 3.79 ± 0.12 4.24 ± 0.11 3.86 ± 0.11 0.06
Kidney (g) 14 1.21 ± 0.04 1.14 ± 0.04 1.26 ± 0.05 0.22
(%) 14 0.33 ± 0.01 0.36 ± 0.01 0.37 ± 0.01 0.21
Intestine
Duodenum (g) 14 0.24 ± 0.01 0.23 ± 0.02 0.20 ± 0.03 0.49
(%) 14 0.87 ± 0.05 0.73 ± 0.07 0.68 ± 0.11 0.43
Jejunum (g) 14 0.65 ± 0.06 0.59 ± 0.03 0.52 ± 0.03 0.08
(%) 14 2.36 ± 0.20 1.85 ± 0.11 1.76 ± 0.10 0.08
Ileum (g) 14 0.19 ± 0.02 0.15 ± 0.01 0.14 ± 0.01 0.19
(%) 14 0.71 ± 0.07 0.48 ± 0.04 0.50 ± 0.05 0.17
Colon (g) 14 0.17 ± 0.01 a 0.12 ± 0.01 b 0.12 ± 0.01 b 0.001
(%) 14 0.62 ± 0.03 a 0.39 ± 0.02 b 0.41 ± 0.03 b 0.001
Adipose Tissue
Epididymal (g) 14 0.49 ± 0.06 1.30 ± 0.16 0.94 ± 0.07 0.06
(%) 14 1.80 ± 0.28 b 4.05 ± 0.37 a 3.17 ± 0.19 a 0.02
Perirenal (g) 14 0.09 ± 0.01 0.37 ± 0.07 0.21 ± 0.02 0.18
(%) 14 0.34 ± 0.05 c 1.15 ± 0.16 a 0.71 ± 0.04 b 0.05
Mesenteric (g) 14 0.25 ± 0.06 0.38 ± 0.06 0.25 ± 0.02 0.58
(%) 14 0.91 ± 0.20 1.18 ± 0.16 0.85 ± 0.07 0.61
Subcutaneous (g) 14 0.25 ± 0.02 b 0.72 ± 0.10 a 0.39 ± 0.02 b 0.03
(%) 14 0.90 ± 0.07 b 2.24 ± 0.23 a 1.34 ± 0.08 b 0.01
Brown (g) 14 0.08 ± 0.01 0.13 ± 0.01 0.09 ± 0.01 0.32
(%) 14 0.28 ± 0.05 0.42 ± 0.03 0.31 ± 0.03 0.33

Abbreviations: LFD, low fat diet; HFD, high fat diet; PL, placebo; APN, adiponectin; The p-overall refers to the p value after performing a one-way analysis of variance for the investigated parameter. For the parameters showing a p-overall <0.05, a post-hoc analysis between the different groups was performed (Means with different letters a,b,c are significantly different, p <0.05). P-overall values were adjusted for body weight.

**

The values measured by MRI.